Immunai

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
Immunai's mission is to transform immunology by pioneering single-cell technologies coupled with the most cutting-edge AI methods. Immunai is a venture funded start-up headquartered in NYC.

Immunai's Scientific Advisory Board includes Dan Littman, Eran Segal, Regina Barzilai, Anshul Kundaje, and has strategic partnerships with some of the most prestigious oncology centers in the world.
Company Type:
Company Website:
Company HQ State:
New York
Company HQ Country:
United States
Year Founded:
2018
Main Therapeutic Focus:
Lead Product in Development:
DeepImmune
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Co-founder
Immunai